MONOCYCLIC PYRIDINE DERIVATIVE
The present invention discloses a compow1d represented by the following formula (IA) or a pharmaceutically acceptable salt thereof: wherein n represents 0 to 2; A represents an arylene group or a heteroarylene group; G represents a single bond, an oxygen atom or -CH2-; E represents a nitrogen-contai...
Saved in:
Main Authors | , , , , , , , |
---|---|
Format | Patent |
Language | English |
Published |
20.10.2020
|
Online Access | Get full text |
Cover
Loading…
Summary: | The present invention discloses a compow1d represented by the following formula (IA) or a pharmaceutically acceptable salt thereof: wherein n represents 0 to 2; A represents an arylene group or a heteroarylene group; G represents a single bond, an oxygen atom or -CH2-; E represents a nitrogen-containing non-aromatic heterocycle; R1 represents an alkoxy group, an alkoxy alkoxy group or the like; R2 represents a hydrogen atom, a halogen atom, a hydroxyl group, an alkyl group, a hydroxy alkyl group, a nitrogen-containing non-aromatic heterocyclic group or the like; R3 represents a hydrogen atom, an alkyl group, an a1koxy group or the like; and R4 represents a C1-6 alkyl group, with the proviso that when E represents an azetidine ring and R2 or R3 is present on a nitrogen atom on the azetidine ring, the R2 or R3 does not represent a hydrogen atom. |
---|---|
Bibliography: | Application Number: MY2015PI702696 |